Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Scholar Rock has achieved success in a drug study for spinal muscular atrophy, potentially setting a new standard for treatment. Judo Bio has debuted with $100 million funding to develop RNA drugs for kidney targets. Intellia has begun late-stage testing of a CRISPR therapy for a rare swelling disease. GSK's Viiv is expanding the supply of an HIV drug in Africa. Biotech IPOs are crucial for the industry, with companies like Upstream Bio and Camp4 Therapeutics setting price ranges for their planned IPOs. Overall, the biopharma industry continues to see advancements in research, development, and expansion of treatments for various diseases.In other news, a new CMS proposed rule targets brokers and Walgreens has hired a new chief commercial officer. There is a need for stronger CMS oversight on hospital pricing compliance as the Government Accountability Office suggests. Baxter is unsure when their North Carolina facility hit by Hurricane Helene will be operational, affecting product purchases and patient care. Healthcare Dive provides in-depth journalism and insight into healthcare news and trends for industry professionals.Honda has released a new ad paying tribute to Formula 1 icon Ayrton Senna, leveraging the growing viewership for the sport in the U.S. Marketers attending Advertising Week New York 2024 are advised to stay informed on topics like AI, retail media, and sports marketing. Brands are encouraged to prepare to use Rich Communication Services (RCS) for mobile communication as Apple adopts this messaging standard. First-party data strategies are becoming increasingly popular among marketers seeking more effective ways to engage with customers. Campbell's Chunky has launched a new campaign featuring football players like Jason Kelce enjoying the hearty soup in humorous settings. Marketing Dive provides insights into marketing and advertising trends for decision-makers in competitive industries.Thank you for tuning in to Pharma and Biotech daily.